Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas

American Journal of Gastroenterology

Volumn 102, Issue 10, 2007, Pages 2259-2264

  Morikawa, Tamiya ^a   Kato, Jun ^a   Yamaji, Yutaka ^b   Wada, Ryoichi ^c   Mitsushima, Toru ^c   Sakaguchi, Kohsaku ^a   Shiratori, Yasushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kameda General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADENOMA; ADULT; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 34848918823     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01404.x     Document Type: Article

References (41)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993 328 : 1365 71.
2. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996 348 : 1467 71.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996 348 : 1472 7.
4. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993 85 : 1311 8.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 343 : 1603 7.
6. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996 334 : 155 9.
7. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993 104 : 1661 8.
8. Castiglione G, Zappa M, Grazzini G, et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 1996 74 : 141 4.
9. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005 129 : 422 8.
10. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity. JAMA 1990 264 : 76 8.
11. Wong WM, Lam SK, Cheung KL, et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003 97 : 2420 4.
12. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001 345 : 555 60.
13. Ahlquist DA, McGill DB, Schwartz S, et al. Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med 1985 312 : 1422 8.
14. Hofstad B, Vatn MH, Andersen SN, et al. Growth of colorectal polyps: Redetection and evaluation of unresected polyps for a period of three years. Gut 1996 39 : 449 56.
15. Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology 1987 93 : 1009 13.
16. Correa P, Strong JP, Reif A, et al. The epidemiology of colorectal polyps: Prevalence in New Orleans and international comparisons. Cancer 1977 39 : 2258 64.
17. Butterly LF, Chase MP, Pohl H, et al. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol 2006 4 : 343 8.
18. Church JM. Clinical significance of small colorectal polyps. Dis Colon Rectum 2004 47 : 481 5.
19. Urbanski SJ, Haber G, Kortan P, et al. Small colonic adenomas with adenocarcinoma. A retrospective analysis. Dis Colon Rectum 1988 31 : 58 61.
20. Gschwantler M, Kriwanek S, Langner E, et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: A multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 2002 14 : 183 8.
21. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975 36 : 2251 70.
22. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992 326 : 658 62.
23. Akiyama Y, Iwanaga R, Ishikawa T, et al. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability. Cancer 1996 78 : 2478 84.
24. Gervaz P, Bouzourene H, Cerottini JP, et al. Dukes B colorectal cancer: Distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001 44 : 364 73.
25. Gonzalez EC, Roetzheim RG, Ferrante JM, et al. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001 44 : 251 8.
26. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001 13 : 63 9.
27. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002 101 : 403 8.
28. Okamoto M, Shiratori Y, Yamaji Y, et al. Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc 2002 55 : 548 51.
29. Kim IJ, Kang HC, Park JH, et al. Development and applications of a beta-catenin oligonucleotide microarray: Beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin Cancer Res 2003 9 : 2920 5.
30. Gervaz P, Bucher P, Neyroud-Caspar I, et al. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: A population-based study. Dis Colon Rectum 2005 48 : 227 32.
31. Okamoto M, Kawabe T, Yamaji Y, et al. Flat-type early colorectal cancer preferentially develops in right-sided colon in older patients. Dis Colon Rectum 2005 48 : 101 7.
32. Russo A, Bazan V, Iacopetta B, et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: Influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005 23 : 7518 28.
33. Yiu R, Qiu H, Lee SH, et al. Mechanisms of microsatellite instability in colorectal cancer patients in different age groups. Dis Colon Rectum 2005 48 : 2061 9.
34. Koushik A, Tranah GJ, Ma J, et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006 119 : 1863 8.
35. Lawes DA, Pearson T, Sengupta S, et al. Is MSI-H of value in predicting the development of metachronous colorectal cancer? Eur J Cancer 2006 42 : 473 6.
36. Wu X, Cokkinides V, Chen VW, et al. Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex. Cancer 2006 107 (Suppl 5 1121 7.
37. Tada S, Yao T, Iida M, et al. A clinicopathologic study of small flat colorectal carcinoma. Cancer 1994 74 : 2430 5.
38. Abe S, Terai T, Sakamoto N, et al. Clinicopathological features of nonpolypoid colorectal tumors as viewed from the patients' background. J Gastroenterol 2006 41 : 325 31.
39. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003 63 : 4878 81.
40. Young J, Barker MA, Simms LA, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005 3 : 254 63.
41. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: A prospective study of patients undergoing colonoscopy. Gastroenterology 2006 131 : 1400 7.